Provided by Tiger Trade Technology Pte. Ltd.

Plus Therapeutics, Inc.

3.87
0.0000
Volume:- -
Turnover:- -
Market Cap:26.56M
PE:-1.08
High:3.87
Open:3.87
Low:3.87
Close:3.87
52wk High:23.43
52wk Low:2.90
Shares:6.86M
Float Shares:6.46M
Volume Ratio:1.39
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5690
EPS(LYR):-7.2500
ROE:-614.05%
ROA:-135.36%
PB:4.86
PE(LYR):-0.53

Loading ...

Plus Therapeutics to Trade on NASDAQ as Cerenome Under CNSY Ticker from Aug. 3

Reuters
·
Jul 31

Press Release: Cerenome Launches as an Integrated CNS Oncology Company

Dow Jones
·
Jul 31

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

GlobeNewswire
·
Jul 28

Plus Therapeutics Signs Medical Mutual Coverage Deal for Cnside CSF Tumor Cell Assay in Ohio, Kentucky

Reuters
·
Jul 21

Plus Therapeutics - to Change Name to Cerenome, and Ticker to Cnsy on August 3, 2026

THOMSON REUTERS
·
Jul 21

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for Cnside® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

THOMSON REUTERS
·
Jul 21

Plus Therapeutics, Genomic Testing Cooperative partner on sequencing technology

TIPRANKS
·
Jul 16

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-generation Sequencing into the Cnside® Csf Assay Platform

THOMSON REUTERS
·
Jul 16

Plus Therapeutics Partners with Genomic Testing Cooperative to Add NGS to Cnside CSF Assay Platform

Reuters
·
Jul 16

Plus Therapeutics reports NCCN Central Nervous System Cancers guidelines update

TIPRANKS
·
Jul 14

Plus Therapeutics Flags Availability of CNS Cancers Guidelines Update Release

Reuters
·
Jul 14

Plus Therapeutics Provides Mid-year Business Update Including Corporate Rebranding

Reuters
·
Jul 06

Analysts Are Bullish on These Healthcare Stocks: Plus Therapeutics (PSTV), Harrow Health (HROW)

TIPRANKS
·
Jul 01

Plus Therapeutics Reaffirms 2026 Milestones Guidance for Cnside Diagnostics Business

Reuters
·
Jun 30

Plus Therapeutics Rebrands as Cerenome, to Trade as CNSY on NASDAQ from Aug. 3, 2026

Reuters
·
Jun 30

Plus Therapeutics - Affirms 2026 Guidance on Key Milestones Including Cnside Diagnostics

THOMSON REUTERS
·
Jun 30

Plus Therapeutics - to Become Cerenome, NASDAQ Ticker to Cnsy Effective August 3, 2026

THOMSON REUTERS
·
Jun 30

Plus Therapeutics Provides Mid-year Business Update Including Corporate Rebranding

THOMSON REUTERS
·
Jun 30

Plus Therapeutics Unit Cnside Signs National Coverage Deal with Elevance Health for CSF Cancer Assay

Reuters
·
Jun 25

Plus Therapeutics to Provide Business Update Call on June 30, 2026

THOMSON REUTERS
·
Jun 23